DNA, 23andMe and Regeneron
Digest more
Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe’s assets for $256 million after coming out on top at a bankruptcy auction for the once-sizzling DNA-testing startup.
21h
Stocktwits on MSNRegeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D EffortsDrugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),